Gardasil and Cervical Cancer

Gardasil and Cervical Cancer

Gardasil Cervical CancerThe U.S. Food and Drug Administration approved the Gardasil human papillomavirus (HPV) vaccine in 2006 after being “fast-tracked” over six short months. The FDA’s fast-track process is designed to facilitate the development, and expedite the review of, drugs or vaccines to treat serious conditions and fill an unmet medical need.

Some have argued that Merck received fast-track approval based on the company’s theory that HPV alone causes cervical cancer, and that Gardasil could eliminate cervical cancer and other HPV-associated cancers. According to Gardasil lawsuits, Merck’s theory is unproven. Gardasil has never been shown to prevent cervical or any other kind of cancer.

Merck has expressly represented through statements it made in its publications, television advertisements, billboards, print advertisements, online advertisements and website, and other written materials intended for consumers, patients, parents of minor-aged patients, medical providers and the general public, that Gardasil was safe and effective at preventing cancer.

For example, Merck’s “One Less” television and print advertisement campaign stated that Gardasil was safe and effective in preventing cervical cancer, that Gardasil was a “cervical cancer vaccine” and that any young girl who was vaccinated with Gardasil would be “one less” woman with cervical cancer. The ubiquitous nature of these Gardasil commercials and the Gardasil marketing campaign gave the impression that cervical cancer was on the rise and more prevalent than it actually was, and that all good mothers vaccinate their daughters with the “cervical cancer vaccine.”

According to data from the National Cancer Institute’s (“NCI”) Surveillance, Epidemiology and End Results Program (“SEER”), the incidence of deaths from cervical cancer prior to Gardasil’s introduction in the U.S. had been steadily declining for years and, in 2006, was 2.4 per 100,000 women or approximately 1 in every 42,000 women. The currently available rate is essentially unchanged, 2.2 per 100,000 women, based on data through 2017.

The median age of death from cervical cancer is 58, and teenage girls essentially have zero risk of dying from cervical cancer.

Public health officials have long recommended the Pap test (also known as Pap Smear), which detects abnormalities in cervical tissue, as the most effective frontline public health response to the disease.

Since its introduction, cervical cancer screening through the Pap test has reduced the rates of cervical cancer in developed countries by up to 80%. Incidences of cervical cancer have been declining dramatically worldwide as countries have implemented Pap screening programs.

New cases of cervical cancer in the U.S. affect approximately 0.6% of women in their lifetime. For those who are diagnosed, cervical cancer is largely treatable, with a five-year survival rate of over 90% when the cancer is caught early.

Our firm believes the FDA’s fast-track approval of Gardasil left unanswered material questions relating to the vaccine’s effectiveness and safety, especially considering some research has shown that Gardasil may increase the risk of developing cervical cancer.

  • Paxil Pediatric Class Action $63 Million
  • Third-Party Payer Class Action $40 Million
  • Defective Drug Class Action $28 Million
  • Celexa-Lexapro Pediatric Class Action $10 Million
  • Drug Injury $9 Million
  • Pharmaceutical Settlement $105 Million
/

Merck’s Gardasil Myth: That HPV and Cervical Cancer Are Inexorably Linked

Whether the FDA considers a condition “serious” enough for fast-tracked approval of a drug or vaccine depends on factors that include “survival, day-to-day functioning, or the likelihood that the condition, if left untreated, will progress from a less severe condition to a more serious one.”

In its bid to fast-track Gardasil and prove that the condition it treats is “serious,” Merck presented misleading data to the FDA suggesting that HPV infections and some cervical interepithelial neoplasia (CIN) lesions inexorably result in cancer, hence the urgent need for the HPV vaccine.

While HPV is the most common sexually transmitted disease, research shows that over 90% of HPV infections cause no clinical symptoms, are self-limited, are removed from the human body by its own immunological mechanisms, and disappear naturally from the body following an infection.

“The Baum, Hedlund firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”

- From Best Lawyers® Best Law Firms
  • Best Law Firms 2021
    Best Law Firms 2021

    The U.S. News – Best Lawyers® “Best Law Firms” rankings are based on lawyer evaluations, peer review from leading attorneys in their field, and review of additional information provided by law firms as part of the formal submission process.

  • National Trial Lawyers Top 100
    National Trial Lawyers Top 100

    The National Trial Lawyers Top 100 recognized the law firms of Baum Hedlund Aristei & Goldman, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the groundbreaking case of Dewayne “Lee” Johnson v. Monsanto Company.

  • Elite Trial Lawyers
    Elite Trial Lawyers

    NLJ and American Lawyer Media honor law firms and attorneys as Elite Trial Lawyers for their cutting-edge legal work on behalf of plaintiffs in practice areas ranging from mass torts to securities litigation.

  • AV Top Ranked Law Firm
    AV Top Ranked Law Firm

    Less than one-half of one percent of firms across the nation have achieved this ranking. A firm must have a high percentage of lawyers who have achieved the prestigious AV® Preeminent rating by Martindale-Hubbell®.

  • Listed in Best Lawyers
    Listed in Best Lawyers

    Best Lawyers is the oldest and most respected peer-review publication in the legal profession. A listing in Best Lawyers is widely regarded by both clients and legal professionals as a significant honor, conferred on a lawyer by his or her peers.

  • National Board of Trial Advocacy
    National Board of Trial Advocacy

    The National Board of Trial Advocacy is dedicated to bettering the quality of trial advocacy in our nation’s courtrooms and helping consumers find experienced and highly qualified trial lawyers.

  • AV Rated
    AV Rated

    An AV® rating reflects an attorney who has reached the heights of professional excellence. The rating signifies the highest legal ability, and very high adherence to professional standards of conduct, ethics, reliability, and diligence.

  • Super Lawyers
    Super Lawyers

    Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement.

  • Nation's Top 1%
    Nation's Top 1%

    The NADC is an organization dedicated to promoting the highest standards of legal excellence. Only the elite few attorneys are invited to join the NADC, less than 1% of practicing attorneys in the U.S.

  • Multi-Million Dollar Advocates Forum
    Multi-Million Dollar Advocates Forum

    Multi-Million Dollar Advocates Forum is one of the most prestigious groups of trial lawyers in the United States.  Membership is limited to attorneys who have won million and multi-million-dollar verdicts and settlements.

  • Bar Register of Preeminent Lawyers
    Bar Register of Preeminent Lawyers

    The Bar Register is the definitive guide to the most distinguished law firms in America. It includes only those select law practices that have earned the highest rating in the Martindale-Hubbell Law Directory and have been designated by their colleagues as preeminent in their field.

/

Medical researchers have identified more than 200 strains of the HPV virus. Of those, 12-18 strains are linked to cervical cancer.

Gardasil was brought to market to prevent just four strains of HPV (HPV Strain Types 6, 11, 16, and 18), of which only two (Types 16 and 18) are linked to cervical cancer. Subsequently, Merck sought approval for Gardasil 9, which contains the same ingredients as the original Gardasil, but in higher quantities that purportedly guarded against five additional HPV strains (HPV Strain Types 31, 33, 45, 52 and 58).

Cervical cancer is a multi-factor disease with persistent HPV infections seeming to play a role, along with many other environmental and genetic factors, including smoking cigarettes or exposure to other toxic smoke sources, long-term use of oral contraceptives, nutritional deficiencies, multiple births (especially beginning at an early age), obesity, inflammation, and other factors. Not all cervical cancer is associated with HPV types in the vaccines and not all cervical cancer is associated with HPV at all.

Merck has claimed that Gardasil can eliminate cervical cancer and other HPV-associated cancers. However, according to Gardasil lawsuits, Merck knows that the Gardasil vaccines cannot eliminate all cervical cancer or any other cancer that may be associated with HPV. In fact, some studies indicate that Gardasil may actually cause the cancer it purportedly prevents.

Contrary to Merck’s Claims, Gardasil May Increase the Risk of Developing Cervical Cancer

HPVMerck markets its Gardasil vaccines as anti-cancer products. However, the original Gardasil label states: “Gardasil has not been evaluated for the potential to cause carcinogenicity or genotoxicity.” The Gardasil 9 label states: “Gardasil 9 has not been evaluated for the potential to cause carcinogenicity, genotoxicity or impairment of male fertility.”

According to the Gardasil litigation, the HPV vaccines may themselves actually cause cancer or mutagenetic changes that can lead to cancer.

Peer-reviewed studies, including the Centers for Disease Control and Prevention’s (CDC) own studies, suggest that the suppression of the HPV strains targeted by Gardasil may actually open the ecological niche for replacement by more virulent strains. Put more simply, the research indicates Gardasil may increase the chances of getting cancer.

These studies include:

According to Gardasil lawsuits, Merck concealed from the public data from its clinical trials indicating that the HPV vaccines may enhance the risk of cervical cancers in women.Some clinical trial participants have developed cancer, including cervical cancer, the lawsuits allege.

Merck’s research showed that women exposed to HPV before being vaccinated were 44.6% more likely to develop cancerous lesions compared to unvaccinated women, even within a few years of receiving the vaccine. In other words, Merck’s studies suggest that its HPV vaccines may cause cancer in women previously exposed to HPV, particularly if they also have a current infection.

More damaging evidence linking cervical cancer to Gardasil – cervical cancer rates are climbing rapidly in places where Gardasil has a high uptake.

An Alabama study shows that the counties with the highest Gardasil uptakes also had the highest cervical cancer rates. After Gardasil was introduced in Britain, cervical cancer rates among young women aged 25 to 29 surged by 54%. In Australia, government data reveals a sharp increase in cervical cancer rates in young women following the implementation of the Gardasil vaccine. The most recent data reveals that 13 years after Gardasil was released and pushed upon teenagers and young adults, there has been a 16% increase in 25 to 29-year-olds and a 30% increase in 30 to 34-year-old women contracting cancer – corroborating the clinical trial data that Gardasil may increase the risk of cervical cancer, particularly in patients who had previous HPV infections.

Have more questions about the Gardasil HPV vaccine? Check out our Gardasil FAQ page.

Gardasil Lawyers Fighting for Victims

Despite data demonstrating that Gardasil can increase the risk of cancer in young women who previously have been exposed to HPV, in order to increase profits, Merck’s Gardasil labels and promotional material do not inform patients and medical doctors of this important risk factor.

The class action attorneys at Baum Hedlund Aristei & Goldman are actively filing lawsuits on behalf of individuals who were harmed by the Gardasil vaccine. If you or a member of your family suffered an adverse reaction after a Gardasil injection, our firm can help you. Even if you suffered from Gardasil side effects years later, you may have a claim.

Call (855) 948-5098 today or contact us for a free and confidential case evaluation.

Firm Reviews

What Our Clients Are Saying
  • Top Legal Minds in the Country

    “The Baum, Hedlund firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”

    - From Best Lawyers® Best Law Firms
  • I Can’t Imagine a Better Law Firm

    “Multiple lawyers recommended Baum Hedlund to me and I have been consistently impressed with the quality of their work.”

    - Best Law Firms Survey
  • Diligent & Professional Representation

    “Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”

    - W.T.
  • Our Best Interest Was Always Number One on Your List

    “A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”

    - G.C. & C.C
  • We Have Never Met a More Wonderful Group of People

    “It is obvious that the people at Baum, Hedlund, Aristei, & Goldman believe in what they do. And that you all really care about your clients.”

    - The B. Family
/